37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers

Spectrum of Acute Odontogenic Conditions

Odontogenic pain and infections account for millions of primary care and emergency department visits annually. Primary care clinicians must distinguish self-limited pulpal inflammation from deep tissue infections requiring urgent dental intervention, while applying rigorous antimicrobial stewardship principles to curb the widespread overprescription of unnecessary antibiotics for localized toothaches.

                  SPECTRUM OF ODONTOGENIC PATHOLOGY

   Dental Caries ───────> Reversible Pulpitis ───────> Irreversible Pulpitis
   (Enamel/Dentin)        • Pain <15 sec with cold/sweet  • Spontaneous throbbing pain
                          • Resolves on stimulus removal   • Lingers >30 sec to hours
                          • Tooth vital; Dental filling    • Nocturnal awakening
                                                           • Root canal or extraction
                                                                    │
                                                                    ▼
    Ludwig Angina <─────── Facial Cellulitis <─────── Periapical Abscess
    (Deep Neck Infection)  (Spreading Infection)      • Pulpal necrosis through apex
    • Mandibular 2nd/3rd   • Systemic signs           • Exquisite percussion tenderness
    • Submandibular woody  • ANTIBIOTICS INDICATED:   • Gumboil / fluctuance
    • AIRWAY EMERGENCY!      Amox-Clav or Clindamycin • Drainage / Root canal

1. Reversible Pulpitis

• Pathophysiology: Dental caries penetrates the enamel and invades the dentin, exposing microscopic dentinal tubules. Fluid movement within these tubules stimulates mechanoreceptors and A-delta sensory nerve fibers in the dental pulp. The pulpal tissue is hyperemic and inflamed but remains vital, vascularized, and capable of complete repair once the irritant is removed.
• Clinical Presentation:
  • Mild to moderate, sharp, transient pain provoked by external stimuli: cold liquids, hot foods, sweets, or sour foods.
  • The pain lasts only seconds (<10 to 15 seconds) and resolves immediately upon removal of the offending stimulus.
  • Absence of spontaneous, unprovoked tooth pain.
  • Absence of pain with tooth percussion or chewing.
• Management:
  • Routine dental referral for restorative dental filling (removal of decayed dentin and sealing with composite resin or amalgam).
  • Analgesics are generally unnecessary or limited to over-the-counter NSAIDs (e.g., ibuprofen 400 mg PRN).
  • Antibiotics are strictly NOT indicated.

2. Irreversible Pulpitis

• Pathophysiology: Carious destruction breaches the pulp chamber directly, allowing polymicrobial bacterial invasion of the vascularized dental pulp. Severe acute inflammation inside the rigid, non-compliant dentin chamber leads to elevated intraluminal pulpal pressure, microvascular collapse, pulpal ischemia, microabscess formation, and progressive liquefactive necrosis.
• Clinical Presentation:
  • Severe, intense, spontaneous, continuous, or throbbing toothache.
  • Pain persists for prolonged periods (minutes to hours, often >30 seconds to several minutes) after thermal stimulation.
  • Heat characteristically exacerbates the pain; in advanced stages with gas-producing anaerobic necrosis, cold liquids may paradoxically alleviate the pain temporarily by contracting trapped gases.
  • Nocturnal pain that awakens the patient from sleep is a classic hallmark.
  • Pain is often poorly localized or referred along branches of the trigeminal nerve (V2 maxillary or V3 mandibular).
  • In later stages, extension to the apical periodontal ligament produces mild sensitivity to percussion.
• Management:
  • Definitive Treatment: Urgent dental referral for pulpectomy (complete extirpation of the pulpal tissue / initial stage of root canal therapy) or tooth extraction.
  • Analgesia: First-line medical therapy is scheduled non-steroidal anti-inflammatory drugs: Oral Ibuprofen 400 to 600 mg every 6 hours combined or alternated with Oral Acetaminophen 500 to 1,000 mg every 6 hours. Randomized trials show NSAIDs provide superior analgesia compared to opioids for pulpal pain by directly inhibiting tissue prostaglandins.
  • Antibiotic Stewardship Rule: Systemic antibiotics are strictly NOT indicated for irreversible pulpitis without systemic spread! Antibiotics do not relieve odontogenic pain, cannot penetrate the devascularized necrotic pulp chamber, and do not prevent progression to periapical disease without mechanical pulpal debridement.

3. Periapical Abscess (Alveolar Abscess)

• Pathophysiology: Complete necrosis of the dental pulp allows polymicrobial oral flora (predominantly obligate anaerobes: Peptostreptococcus, Prevotella, Porphyromonas, Fusobacterium, and viridans streptococci) to exit through the apical foramen of the tooth root into the surrounding periapical alveolar bone and periodontal ligament. The resulting intense neutrophilic response creates a localized purulent collection.
• Clinical Presentation:
  • Severe, constant, intense, localized, throbbing tooth pain.
  • Exquisite tenderness to light tapping or percussion of the tooth (pathognomonic sign of periapical inflammation).
  • Sensation that the offending tooth is "elongated," "raised," or extruded in its socket, making gentle contact with opposing teeth excruciating.
  • Localized, fluctuant, erythematous swelling of the buccal gingiva adjacent to the root apex (parulis or "gumboil"); spontaneous rupture releases foul-tasting pus, producing dramatic immediate pain relief.
  • Tender regional submandibular or cervical lymphadenopathy.
• Management & Antibiotic Stewardship:
  • Primary Management: Urgent dental referral for definitive source control: endodontic drainage (trephination through the tooth crown), tooth extraction, or incision and drainage (I&D) of fluctuant submucosal gingival abscesses.
  • When Antibiotics ARE Indicated:
    1. Evidence of systemic spread: fever (temperature ≥38.0°C), tachycardia, chills, diaphoresis, malaise;
    2. Spreading facial cellulitis or diffuse soft-tissue swelling;
    3. Trismus (inability to open the mouth normally, interincisal opening <35 mm);
    4. Extension to regional fascial spaces or deep cervical chains;
    5. Severely immunocompromised host (neutropenia, advanced HIV/AIDS, active chemotherapy, organ transplant).
  • First-Line Antimicrobial Regimens (when systemic criteria are met):
    • Oral Amoxicillin: 500 mg orally three times daily (TID) for 5 to 7 days; OR
    • Oral Amoxicillin-Clavulanate (Augmentin): 875/125 mg orally twice daily (BID) for 5 to 7 days (preferred if refractory or previous beta-lactam exposure due to beta-lactamase-producing anaerobes);
    • In Penicillin-Allergic Patients:
      • Oral Clindamycin: 300 to 450 mg orally three to four times daily for 5 to 7 days (covers oral Gram-positive cocci and oral anaerobes; monitor for C. difficile);
      • Oral Azithromycin: 500 mg orally on day 1, then 250 mg once daily on days 2 through 5;
      • Oral Cephalexin: 500 mg orally four times daily (acceptable only for mild, non-anaphylactic, non-IgE mediated penicillin reactions).

Summary: Comparison of Common Odontogenic Conditions

---

Deep Neck Space Infections: Ludwig Angina

Ludwig angina is a rapidly spreading, potentially catastrophic bilateral cellulitis and phlegmon involving the submandibular, sublingual, and submental fascial spaces, historically associated with a mortality rate exceeding 50% prior to modern airway intervention and antimicrobial therapy.

Pathogenesis & Anatomic Vulnerability

• More than 80% to 90% of cases arise from an odontogenic source, most commonly an untreated periapical abscess or dental extraction of the mandibular second or third molars.
• Anatomical Landmark: The roots of the mandibular second and third molars extend deeply into the mandible, lying inferior to the mylohyoid muscle ridge (line). Consequently, an infection eroding through the thin lingual cortical plate of the mandible drains directly into the submandibular space rather than staying confined to the oral cavity, spreading rapidly across the midline to involve all contiguous fascial compartments.
• Microbiology is typically polymicrobial, reflecting mixed normal oral flora: viridans streptococci (Streptococcus anginosus group), Peptostreptococcus, Bacteroides, Prevotella, Porphyromonas, and Fusobacterium nucleatum.

Clinical Presentation & Red Flags

• Severe neck pain, throat pain, dysphagia, odynophagia, and trismus.
• Woody / Brawny Induration: Symmetrical, firm, non-fluctuant, tense, tender "woody" swelling of the bilateral submandibular and submental regions, producing a characteristic thick-necked or "bull neck" appearance.
• Floor of the Mouth Elevation: The sublingual space infection elevates the floor of the mouth, forcing the tongue to protrude superiorly and posteriorly against the hard and soft palate, completely obstructing the oropharynx.
• Airway Compromise Signs: Drooling (inability to swallow secretions), muffled "hot potato" voice, dyspnea, tachypnea, stridor, tripoding posture, and cyanosis.

Emergency Management Protocol

1. Definitive Airway Control (The Paramount Priority):
   • Call immediately for emergency anesthesia and ENT / oral maxillofacial surgery assistance.
   • Blind oral or blind nasotracheal intubation is strictly contraindicated! Attempts at standard direct laryngoscopy or blind intubation frequently fail due to severe lingual displacement and pharyngeal edema, and can trigger fatal laryngospasm, rupture of phlegmon with purulent aspiration, or complete irreversible airway obstruction.
   • Airway of choice: Awake fiberoptic nasotracheal intubation performed in the operating room, or emergent surgical airway (awake tracheostomy or cricothyroidotomy) under local anesthesia.
2. Broad-Spectrum Intravenous Antimicrobials:
   • Initiate immediate high-dose IV empiric coverage targeting oral Gram-positive aerobes, anaerobes, and potential resistant pathogens:
     • Preferred First-Line: Intravenous Ampicillin-Sulbactam (Unasyn) 3 grams IV every 6 hours; OR
     • Alternative: Intravenous Ceftriaxone 2 grams daily PLUS Intravenous Metronidazole 500 mg every 8 hours;
     • In Penicillin-Allergic or Suspected MRSA: Intravenous Vancomycin (15 to 20 mg/kg IV every 12 hours) PLUS Intravenous Metronidazole (500 mg IV every 8 hours) PLUS Intravenous Cefepime (2 g IV every 8 hours) or Levofloxacin (750 mg IV daily).
3. Surgical Decompression & Source Control:
   • Emergent operative exploration for external fascial incision, wide bilateral submandibular decompression, drainage of any localized collections, and extraction of the offending infected molar.

---

Oral Mucosal Ulcerations: Differential Diagnosis & Management

Oral mucosal ulcers are among the most frequent oral complaints in primary care. Establishing the precise anatomical location (keratinized vs. non-keratinized mucosa), morphology, scrapability, and recurrence pattern allows rapid differentiation between aphthous ulcers, herpes simplex virus, and candidiasis.

1. Recurrent Aphthous Stomatitis (RAS / Canker Sores)

• Epidemiology & Pathophysiology: The most common ulcerative disease of the oral mucosa, affecting up to 20% of the population. Mediated by an abnormal T-cell (CD8+ cytotoxic) immune response directed against oral keratinocytes, triggered by local mucosal microtrauma (accidental biting, hard toothbrushes), emotional stress, systemic illness, hormonal fluctuations, or sodium lauryl sulfate in commercial dentifrices.
• Clinical Subtypes:
  • Minor Aphthae (80% to 85%): Small (<1 cm diameter, typically 2 to 5 mm), shallow, round-to-oval ulcers with a gray-yellow fibrinous pseudomembranous necrotic base surrounded by a prominent, sharply demarcated erythematous inflammatory halo. Extremely painful. Resolve spontaneously within 7 to 14 days without scarring.
  • Major Aphthae (Sutton Disease, 10% to 15%): Large (>1 cm diameter), deep, punched-out, crateriform ulcers with elevated borders. Extremely painful, persisting for 2 to 6 weeks or months, and frequently heal with permanent scar formation and tissue distortion.
  • Herpetiform Aphthae (5% to 10%): Crops of numerous (10 to 100) tiny, pinpoint (1 to 3 mm) shallow ulcers that coalesce into irregular ragged ulcerated plaques. Important: Despite the name, they are not caused by herpes simplex virus and do not display a vesicular stage.
• Anatomic Hallmark: Aphthous ulcers occur STRICTLY ON NON-KERATINIZED, MOBILE ORAL MUCOSA:
  • Buccal mucosa (inner cheeks);
  • Labial mucosa (inner lips);
  • Ventral surface of the tongue;
  • Floor of the mouth and soft palate.
  • Exam Pearl: Aphthous ulcers never occur on keratinized mucosa (vermilion border, hard palate, attached gingiva) in immunocompetent hosts.
• Evidence-Based Pharmacotherapy:
  • Topical High-Potency Corticosteroids (First-Line):
    • Triamcinolone acetonide 0.1% dental paste (Kenalog in Orabase): Applied directly to the dried ulcer 2 to 4 times daily after meals and at bedtime until healed;
    • Fluocinonide 0.05% gel or Clobetasol propionate 0.05% gel/ointment for refractory or major aphthae;
  • Topical Analgesics & Protectants: Viscous lidocaine 2% solution applied locally with a cotton swab before meals; over-the-counter benzocaine 10% to 20% gel; oral sucralfate slurry swish and spit;
  • Antiseptic Rinses: Chlorhexidine gluconate 0.12% oral rinse twice daily to prevent secondary bacterial superinfection.
• Systemic Screening in Complex / Severe / Recurrent Aphthae:
  • While isolated minor aphthae require no laboratory workup, patients with severe, recurrent, or atypical aphthae should be evaluated for underlying systemic diseases:
    1. Behçet Disease: Triad of recurrent oral aphthae (≥3 times in 12 months) PLUS recurrent genital aphthae, ocular uveitis/retinal vasculitis, and cutaneous lesions (erythema nodosum, pathergy test positive);
    2. Celiac Disease: Screen with serum tissue transglutaminase IgA (tTG-IgA);
    3. Inflammatory Bowel Disease (Crohn Disease): Aphthous ulcers, abdominal pain, diarrhea, elevated fecal calprotectin;
    4. Micronutrient Deficiencies: Serum Vitamin B12, folate, ferritin / iron saturation, and zinc levels;
    5. HIV Infection: Screen in high-risk patients or persistent giant major aphthae;
    6. PFAPA Syndrome: In pediatric patients with Periodic Fevers, Aphthous stomatitis, Pharyngitis, and cervical Adenitis.

2. Herpes Simplex Virus Gingivostomatitis (HSV-1)

• Clinical Presentation: Primary infection typically occurs in young children (aged 6 months to 5 years) or young adults, presenting with high fever, malaise, irritability, cervical lymphadenopathy, and intense oral pain. It begins as crops of multiple small vesicles (1 to 2 mm) that rapidly rupture within 24 hours, coalescing into painful, shallow, clustered erosions with irregular, scalloped borders.
• Anatomic Hallmark: HSV characteristically targets KERATINIZED, BOUND MUCOSA:
  • Vermilion border of the lips (herpes labialis / "cold sores");
  • Hard palate;
  • Attached gingiva (diffusely erythematous, friable, edematous, bleeding gingiva is classic for primary herpetic gingivostomatitis).
• Pharmacotherapy:
  • Systemic antiviral therapy is most effective when initiated within 72 hours of symptom onset:
    • Oral Valacyclovir: 1,000 mg orally twice daily for 7 to 10 days (or 2,000 mg BID for 1 day for recurrent herpes labialis);
    • Oral Acyclovir: 400 mg orally three times daily (or 200 mg 5 times daily) for 7 to 10 days;
  • Supportive care: Hydration, oral analgesics (acetaminophen, ibuprofen), and barrier protectants.

3. Oral Candidiasis (Thrush)

• Etiology & Risk Factors: Overgrowth of the opportunistic fungal commensal Candida albicans, triggered by:
  • Inhaled corticosteroid use (especially metered-dose inhalers used without a valved holding chamber / spacer or without post-inhalation mouth rinsing);
  • Recent systemic broad-spectrum antibiotic therapy;
  • Denture wear (denture stomatitis);
  • Salivary hypofunction (xerostomia, Sjögren syndrome);
  • Immunocompromised states: poorly controlled diabetes mellitus, chemotherapy, systemic corticosteroid therapy, hematologic malignancy, advanced HIV/AIDS (CD4 <200 cells/mcL).
• Clinical Forms & Scrapability Hallmark:
  • Pseudomembranous Candidiasis (Classic Thrush): Hallmark creamy, curd-like white plaques on the buccal mucosa, tongue, soft palate, and pharynx. Diagnostic Hallmark: THE WHITE PLAQUES CAN BE WIPED OFF WITH A TONGUE BLADE OR GAUZE, revealing an underlying erythematous, raw, inflamed, and sometimes bleeding mucosal surface.
  • Distinction from Oral Leukoplakia: Leukoplakia presents as chronic, hyperkeratotic white patches on the lateral tongue or oral mucosa that CANNOT be wiped or scraped off, representing premalignant dysplastic squamous changes requiring biopsy.
  • Erythematous (Atrophic) Candidiasis: Bright red, velvety, painful mucosal depapillation on the dorsal tongue or beneath maxillary dentures.
  • Angular Cheilitis (Perleche): Erythema, maceration, fissuring, and scaling at the oral commissures (lip corners), often coinfected with Staphylococcus aureus.
• Pharmacotherapy:
  • Mild, Localized Disease:
    • Nystatin oral suspension (100,000 units/mL): 4 to 6 mL swish and swallow four times daily (QID) for 7 to 14 days; OR
    • Clotrimazole troches (10 mg): One troche dissolved slowly in the mouth 5 times daily for 7 to 14 days;
  • Moderate-to-Severe, Refractory, or Immunocompromised Host:
    • Oral Fluconazole: 200 mg loading dose on day 1, followed by 100 to 200 mg orally once daily for 7 to 14 days (provides systemic bioavailability and treats concomitant esophageal candidiasis);
  • Denture Stomatitis: The patient must remove dentures at night, clean them thoroughly, and soak them overnight in a chlorhexidine gluconate or antifungal solution; treating the oral mucosa alone will result in immediate reinfection from colonized acrylic dentures;
  • Inhaled Corticosteroid Counseling: Always utilize a valved holding chamber (spacer) and aggressively swish, gargle, and spit tap water immediately following every dose.

Diagnostic Comparison of Common Oral Mucosal Lesions